Fresenius Medical Care | FME - Ebitda

Stock Price
38.84
Daily Change
-0.17 -0.44%
Monthly
1.15%
Yearly
-9.46%
Q2 Forecast
38.53

Fresenius Medical Care reported EUR1.07B in EBITDA for its fiscal quarter ending in December of 2025.





Ebitda Change Date
Akzo Nobel EUR 345M 540M Mar/2026
Alcon AG USD 317M 337M Dec/2025
AstraZeneca USD 5.23B 272M Sep/2025
Bayer EUR 1.97B 457M Dec/2025
Beiersdorf EUR 984M 147M Jun/2025
DaVita Healthcare Partners USD 772.7M 89.45M Dec/2025
Demant DKK 2.76B 165M Dec/2025
E.ON EUR 1.78B 438M Sep/2025
Essilor EUR 3.09B 356M Dec/2024
Fresenius EUR 850M 22M Sep/2025
Fresenius Medical Care EUR 1.07B 142.74M Dec/2025
Genmab DKK 186M 291M Dec/2025
Getinge SEK 3.47B 2.13B Dec/2024
Givaudan CHF 778M 195M Dec/2025
GlaxoSmithKline GBP 3.36B 179M Sep/2025
GN Store Nord DKK 627M 106M Dec/2025
GRIFOLS EUR 347.24M 58.35M Jun/2025
Hikma Pharmaceutical USD 369M 84M Dec/2024
Lonza CHF 1.01B 54M Dec/2025
Merck EUR 1.44B 263M Dec/2025
Novartis USD 4.77B 1.11B Dec/2025
Philips EUR 738M 9M Sep/2025
Roche Holding CHF 12.68B 2.36B Jun/2024
RWE EUR 1.61B 274M Dec/2025
Sanofi EUR 3.31B 3.65B Mar/2026
SAP EUR 3.17B 606M Mar/2026
Smith & Nephew USD 796M 139M Dec/2025